There are 2949 resources available
1199P - Identification of patient specific immune therapy treatment sensitivity by ex vivo testing
Presenter: Fanny Grillet
Session: E-Poster Display
Resources:
Abstract
1200P - Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC
Presenter: Karlijn Joode
Session: E-Poster Display
Resources:
Abstract
1201P - The role of a mini tumour mutational burden (TMB) score generated with a customized NGS panel to predict benefit from immunotherapy
Presenter: Pasquale Lombardi
Session: E-Poster Display
Resources:
Abstract
1202P - Identification of a gene signature closely related to immunosuppressive tumour microenvironment predicting prognosis of patients in EGFR mutant lung adenocarcinoma
Presenter: Jia Li
Session: E-Poster Display
Resources:
Abstract
1203P - Prognostic implication of clinical decision support system (CDSS) for colorectal cancer
Presenter: In Hee Lee
Session: E-Poster Display
Resources:
Abstract
1204P - Expression of cholinesterase is associated with prognosis and response to chemotherapy in advanced gastric cancer
Presenter: Yanzhi Bi
Session: E-Poster Display
Resources:
Abstract
1205P - FACILITATE: A real-world multicentre prospective study investigating the utility of a rapid, fully automated RT-PCR assay vs reference methods (RM) for detecting epidermal growth factor receptor mutations (EGFRm) in NSCLC
Presenter: Michael Hummel
Session: E-Poster Display
Resources:
Abstract
1206P - Computing HRD score by a capture-based NGS panel reveal its prevalence in Chinese breast, ovarian, prostate and pancreatic cancer patients
Presenter: Kefei Huang
Session: E-Poster Display
Resources:
Abstract
1207P - Neurotrophin tyrosine receptor kinase (NTRK) partners identified by next-generation sequencing in Chinese patients with solid tumours
Presenter: Rongrong Li
Session: E-Poster Display
Resources:
Abstract
1208P - EIT PACMAN study results: OncoSignal signaling pathway analysis using FFPE-compatible tests identifies actionable cancer targets in a variety of cancers without actionable mutations
Presenter: Anja Van De Stolpe
Session: E-Poster Display
Resources:
Abstract